Phase II study of NGR-hTNF in combination with doxorubicin in relapsed ovarian cancer patients (Q24633820)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase II study of NGR-hTNF in combination with doxorubicin in relapsed ovarian cancer patients |
scientific article |
Statements
Phase II study of NGR-hTNF in combination with doxorubicin in relapsed ovarian cancer patients (English)
G Scambia
G Amadio
A di Legge
V Masciullo
M Di Stefano
G Citterio
M Mantori
A Lambiase
C Bordignon
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
2 references
2 references
2 references